Alison Betts PhD

Dr. Alison Betts, Ph.D. Prior to joining Applied BioMath, Alison had an extensive modeling and simulation career at Pfizer, Inc., beginning in Sandwich, the UK in 1994. In 2007, she transferred to the translational research group in Groton, CT. Most recently, she was a member of the translational modeling and simulation group in the biomedicines design department in Cambridge, MA, where she was the translational modeling and simulation lead supporting the oncology research unit.

During her career at Pfizer, Inc. Alison supported many research units including pain, cardiovascular, antibacterials, inflammation and immunology, immuno-oncology, and oncology to establish the use of modeling and translational pharmacology to drive projects and increase efficiency and effectiveness in achieving portfolio goals. In these roles, she provided modeling and simulation support to small and large molecule therapeutics at different stages of research and development. Alison specializes in modeling and simulation of novel biotherapeutic drugs, including antibody-drug conjugates, bispecific biologics, T-cell engagers, in order to understand complex mechanisms, validate targets, and translate to the clinic.

Alison graduated from St. Andrews University, Scotland, the UK with a first-class honors degree in biochemistry. She is completing her Ph.D. studies at the University of Leiden, The Netherlands on 'QSP modeling of biotherapeutic drugs in oncology.'